Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant

Z. Zakaria, A. Tivnan, L. Flanagan, D. W. Murray, M. Salvucci, B. W. Stringer, B. W. Day, A. W. Boyd, D. Kögel, M. Rehm, D. F. O'Brien, A. T. Byrne, J. H.M. Prehn

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)
27 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Biochemistry, Genetics and Molecular Biology